RVRC
Revium Rx.Company Information
- Company Name
- Revium Rx.
- CIK
- CIK0001839140
- Category
- Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
- Ticker: Exchange
- RVRC: OTC
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- RVRC
SEC filing data through
Insider Sentiment
- Last purchase
- —
- Last sale
- —
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- —
- Institutional shares owned
- —
- Shares outstanding
- —
- Ownership
- —
Earnings Market Reaction
- Filing date
- 2026-08-13
- Price on filing date
- —
- 1-month reaction
- -14.37%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|
Assets Current | |||||||||
| Cash And Cash Equivalents At Carrying Value | 1 | 1 | 2 | ||||||
| Deposits Assets Current | 1 | 1 | 1 | ||||||
| Restricted Cash Current | 0 | - | - | ||||||
| Other Assets Current | 0 | 0 | 0 | ||||||
| Assets Current | 2 | 2 | 3 | ||||||
Assets Noncurrent | |||||||||
| Property Plant And Equipment Net | 0 | 0 | 0 | ||||||
| Operating Lease Right Of Use Asset | 0 | 0 | 0 | ||||||
| Intangible Assets Net Excluding Goodwill | 2 | 2 | 2 | ||||||
| Goodwill | 3 | 3 | 3 | ||||||
| Assets Noncurrent | 5 | 5 | 5 | ||||||
| Assets | 7 | 8 | 8 | ||||||
Liabilities Current | |||||||||
| Accounts Payable Current | 1 | 0 | 0 | ||||||
| Operating Lease Liability Current | 0 | 0 | 0 | ||||||
| Convertible Notes Payable Current | 0 | 0 | 0 | ||||||
| Liabilities Current | 1 | 2 | 1 | ||||||
Liabilities Noncurrent | |||||||||
| Operating Lease Liability Noncurrent | 0 | 0 | 0 | ||||||
| Derivative Liabilities Noncurrent | 1 | 1 | 1 | ||||||
| Liabilities Noncurrent | 1 | 0 | 0 | ||||||
| Liabilities | 2 | 2 | 1 | ||||||
Stockholders Equity | |||||||||
| Common Stock Value | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 32 | 32 | 32 | ||||||
| Retained Earnings Accumulated Deficit | -26 | -26 | -25 | ||||||
| Stockholders Equity | 6 | 6 | 7 | ||||||
| Liabilities And Stockholders Equity | 7 | 8 | 8 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 10 | 10 | 10 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 250 | 250 | 250 | ||||||
| Common Stock Shares Issued | 61 | 61 | 61 | ||||||
| Shares Outstanding | 61 | 61 | 61 | ||||||
Select a line item above to chart it.
Recent filings
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialRevium Rx. (RVRC) — SEC Financial Statements & Analysis
Revium Rx. (RVRC) is a pharmaceutical preparations company, incorporated in DE. Revium Rx. trades on OTC as: RVRC. Revium Rx. (RVRC)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-13. Based on that filing, Revium Rx. carries a market cap of $101.42M, a P/B ratio of 18.38x, and an enterprise value of $100.58M. On the balance sheet, it maintains a current ratio of 1.91x, a quick ratio of 1.91x, working capital of $885.00K, a debt-to-equity ratio of 0.29x, a debt ratio of 0.22, and net debt of $-841.00K. Figures sourced from SEC EDGAR.
- Market Cap
- $101.42M
- P/B TTM
- 18.38x
- Debt To Equity
- 0.29x
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Revium Rx. in?
Revium Rx. (RVRC) operates in the Pharmaceutical Preparations industry.
What exchange does RVRC trade on?
Revium Rx. (RVRC) trades on the OTC.
Where is Revium Rx. incorporated?
Revium Rx. is incorporated in DE.
When was Revium Rx. (RVRC)'s most recent SEC filing?
Revium Rx. (RVRC)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-13.
What is RVRC's market cap?
Revium Rx. (RVRC) has a market capitalization of $101.42M as of 2026-06-30.